<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08588009045236</udiDi>
    <basicUdiDi>8588009045HYPROMELOZAPR3</basicUdiDi>
    <tradeName>HYPROMELOZA-P® acu pilieni, šķīdums</tradeName>
    <deviceName>HYPROMELOZA-P eye drops, solution</deviceName>
    <manufacturerName>Unimed Pharma spol. s r.o.</manufacturerName>
    <manufacturerSrn>SK-MF-000003111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11</reference>
    <placedOnMarketCountry>Latvia</placedOnMarketCountry>
    <lastUpdated>2026-07-16T09:25:17.424Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437009065044</udiDi>
    <basicUdiDi>8437009065000010017W</basicUdiDi>
    <tradeName>Vidi Pharma Saltvannsdråper 20 x 2 mL</tradeName>
    <deviceName>Saline Solution</deviceName>
    <manufacturerName>Unolab manufacturing, S.L.</manufacturerName>
    <manufacturerSrn>ES-MF-000000272</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PSU-0011</reference>
    <placedOnMarketCountry>Norway</placedOnMarketCountry>
    <lastUpdated>2026-07-16T09:22:49.694Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057509760043</udiDi>
    <basicUdiDi>805750976MDR16FE</basicUdiDi>
    <tradeName>LACTO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ITALDEVICE S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000026487</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NP90LAC010M</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T09:08:58.997Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053787159302</udiDi>
    <basicUdiDi>8053787RSO5863</basicUdiDi>
    <tradeName>Murine tears 15 ml</tradeName>
    <deviceName>RSO58</deviceName>
    <manufacturerName>OMISAN FARMACEUTICI S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000012096</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>PF1593</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:59:59.806Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135272294</udiDi>
    <basicUdiDi>803413527THENOPHTHLMCGLST</basicUdiDi>
    <tradeName>Puro Epithel</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DEX046</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:50:58.066Z</lastUpdated>
  </row>
  <row>
    <udiDi>08029408160699</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Ceramol ofta repair</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS312</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:46:27.428Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260265220087</udiDi>
    <basicUdiDi>426026522ANS3KZG</basicUdiDi>
    <tradeName>medEctoin®Allergy Nasal Spray 1%</tradeName>
    <deviceName>medEctoin® Allergy Nasal Spray 1% / medEctoin® Allergy Nasal Spray 2% / medEctoin® Rhinitis Nasal Spray</deviceName>
    <manufacturerName>bitop AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006543</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>38020</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T06:18:11.652Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260200970916</udiDi>
    <basicUdiDi>426020097BSSC5</basicUdiDi>
    <tradeName>BSS DISTRA-SOL</tradeName>
    <deviceName>Eye-Lotion Balanced salt solution</deviceName>
    <manufacturerName>Serumwerk Bernburg AG</manufacturerName>
    <manufacturerSrn>DE-MF-000005169</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030203</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY BALANCED SALINE SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1221</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T06:17:38.143Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002495</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName>Lubricating eye drops with 0.03% sodium hyaluronate</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0085</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-16T05:10:45.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260764172535</udiDi>
    <basicUdiDi>361563Hyaluronate0.2%NFW9</basicUdiDi>
    <tradeName>Augentropfen 0,2% Hyaluron</tradeName>
    <deviceName>HYALURONATE 0.2% NF</deviceName>
    <manufacturerName>UNITHER INDUSTRIES</manufacturerName>
    <manufacturerSrn>FR-MF-000027437</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>4260764172535</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-16T04:54:04.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>03662042019562</udiDi>
    <basicUdiDi>3662042014260SX</basicUdiDi>
    <tradeName>THEALOZ GEL 15 G</tradeName>
    <deviceName>THEALOZ GEL</deviceName>
    <manufacturerName>LABORATOIRES THEA</manufacturerName>
    <manufacturerSrn>FR-MF-000001384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10027C15L02</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-16T04:52:02.559Z</lastUpdated>
  </row>
  <row>
    <udiDi>03662042007842</udiDi>
    <basicUdiDi>3662042006210SK</basicUdiDi>
    <tradeName>HYABAK 10 ML</tradeName>
    <deviceName>HYABAK</deviceName>
    <manufacturerName>LABORATOIRES THEA</manufacturerName>
    <manufacturerSrn>FR-MF-000001384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1557SH10L09</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-16T04:52:01.765Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588006940282</udiDi>
    <basicUdiDi>08588006940TD004XK</basicUdiDi>
    <tradeName>Ocusan Single-Dose Eye Drops</tradeName>
    <deviceName>Ocusan</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940282</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:17.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588006940251</udiDi>
    <basicUdiDi>08588006940TD002XF</basicUdiDi>
    <tradeName>Siccaforte Eye Gel</tradeName>
    <deviceName>Siccaforte Eye Gel</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940251</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:12.479Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588006940244</udiDi>
    <basicUdiDi>08588006940TD003XH</basicUdiDi>
    <tradeName>Siccasan Eye Gel</tradeName>
    <deviceName>Siccasan Eye Gel</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940244</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:11.679Z</lastUpdated>
  </row>
  <row>
    <udiDi>50380659001012</udiDi>
    <basicUdiDi>038065GMN000255HE</basicUdiDi>
    <tradeName>PERFLUORON</tradeName>
    <deviceName>PERFLUORON Liquid</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000016248</manufacturerSrn>
    <authorisedRepresentativeName>Alcon Laboratories Belgium</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000014721</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030205</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY, PERFLUOROCARBONS PURE AND COMBINED WITH OTHER SUBSTANCES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>200043291</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:31:07.240Z</lastUpdated>
  </row>
  <row>
    <udiDi>00380659001017</udiDi>
    <basicUdiDi>038065GMN000013GL</basicUdiDi>
    <tradeName>PERFLUORON</tradeName>
    <deviceName>Surgical PERFLUORON Kit</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-PR-000037951</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030205</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY, PERFLUOROCARBONS PURE AND COMBINED WITH OTHER SUBSTANCES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0090010018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:23:34.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>00300650802710</udiDi>
    <basicUdiDi>038065GMN000052GW</basicUdiDi>
    <tradeName>BSS PLUS</tradeName>
    <deviceName>BSS PLUS Device</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000016248</manufacturerSrn>
    <authorisedRepresentativeName>Alcon Laboratories Belgium</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000014721</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030203</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY BALANCED SALINE SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00300650802710</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:22:25.139Z</lastUpdated>
  </row>
  <row>
    <udiDi>00300650351201</udiDi>
    <basicUdiDi>038065GMN000011GG</basicUdiDi>
    <tradeName>BSS</tradeName>
    <deviceName>BSS Sterile Irrigating Solution</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000016248</manufacturerSrn>
    <authorisedRepresentativeName>Alcon Laboratories Belgium</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000014721</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030203</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY BALANCED SALINE SOLUTIONS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>0003510150</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T20:22:22.904Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution91W3</udiDi>
    <basicUdiDi>B-salinesolution91W3</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 20ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>91</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:31:11.025Z</lastUpdated>
  </row>
</eudamedExport>